Biogen Idec
Massachusetts-based global biologics company Biogen Idec has announced the retirement of its Chairman William D. Young, who will be replaced by Stelios Papadopoulos.
“Bill took over as chairman at a difficult time for the company, went on to unify the Board, spearheaded the recruitment of a new management team and presided over a time of unprecedented growth for the company. His record will be hard to match,” said the incoming chairman.
Papadopoulos is former Vice Chairman of financial services firm Cowen & Co. and is current Chairman of the Board at Exelixis and Regulus Therapeutics.